A major challenge in tissue engineering is not only achieving the correct cellular organization of an engineered tissue, but also expanding it to a clinically useful size after implantation.

Meanwhile, a phase III failure of Theravance Biopharma Inc.’s norepinephrine reuptake inhibitor ampreloxetine to treat symptomatic neurogenic orthostatic hypotension in patients with the rare disease ...

Late last year Bioworld Merchandising, which licenses and sells a myriad of pop culture-branded clothing and products like Mario baseball caps and “Stranger Things” socks, launched an investment arm ...